Woodward, Inc.
NASDAQWoodward heads into its May 4 Q2 2026 earnings release with a rare alignment of analyst conviction and a stock trading at a meaningful discount to consensus targets. The analyst setup is the standout here. UBS raised its price target to $429 on April 30 — the day before earnings week — while maintaining a Buy rating. RBC Capital initiated coverage at Outperform with a $450 target on…
Snapshot as of 8 May 2026
Woodward heads into its May 4 Q2 2026 earnings release with a rare alignment of analyst conviction and a stock trading at a meaningful discount to consensus targets. The analyst setup is the standout here. UBS raised…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for WWD — free to start on ORTEX.
Sign up for free →Open WWD on ORTEX